The glycosylated‐PEG–oHSV mitigates the immunosuppressive tumor microenvironment by augmenting the infiltration of CD8+ T cells and NK cells, stimulating the secretion of antitumor cytokines, ultimately impeding HCC progression [607]. Here, CD8A is linked to hepatocellular carcinoma.